Insights Blog

This is the final post in a series based on the Complion webinar,  The Future of the Clinical Research Industry, as presented by John Neal, CEO of PCRS Network. In that webinar, John explores a variety of factors that are driving the evolution of clinical research. This post looks at another of John Neal’s predictions.

Because sponsors are increasingly seeking efficiencies, and all stakeholders have an interest in minimizing the time required of, and the potential risk to, volunteers who participate in studies, there will be a decrease in the number of single drug studies in the future. [1]

This post is Part 3 in a series based on the Complion webinar,  The Future of the Clinical Research Industry, as presented by John Neal, CEO of PCRS Network. In that webinar, John explores a variety of factors that are driving the evolution of clinical research.

Inefficient and ineffective. That’s how John Neal sums up his frank assessment of the current state of the clinical research site selection process. John bases that assessment on data available from CenterWatch and other sources. “Something on the order of 50% of all sites that are initiated across all studies don’t meet their original enrollment expectations,” John observes. 

This post is Part 2 in a series based on the Complion webinar,  The Future of the Clinical Research Industry, as presented by John Neal, CEO of PCRS Network. In that webinar, John explores a variety of factors that are driving the evolution of clinical research.

We have the good fortune to live in an age when we are surrounded by technologies that are improving the speed and efficiency with which we can gather information, and the depth and breadth of that information. “In my research I’ve come across dozens of different devices out there that are already being used, some of which are collecting hundreds, and in some cases literally thousands and thousands of data points per second,” John says.

This post introduces a series based on the Complion webinar,  The Future of the Clinical Research Industry, as presented by John Neal, CEO of PCRS Network. In that webinar, John explores a variety of factors that are driving the evolution of clinical research.

No human endeavor is immune to change, and that is certainly true for clinical research. John Neal, CEO of PCRS Network spent a year talking to sponsors, management, and other people in various roles in clinical research in an effort to identify the factors that are shaping the future of clinical research. And while the views vary, one factor looms above all others.